IBDEI0HO ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8589,1,3,0)
 ;;=3^Retinochoroiditis,Dissem,Syphilitic
 ;;^UTILITY(U,$J,358.3,8589,1,4,0)
 ;;=4^094.83
 ;;^UTILITY(U,$J,358.3,8589,2)
 ;;=^266752
 ;;^UTILITY(U,$J,358.3,8590,0)
 ;;=099.3^^58^612^82
 ;;^UTILITY(U,$J,358.3,8590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8590,1,3,0)
 ;;=3^Reiter's Disease
 ;;^UTILITY(U,$J,358.3,8590,1,4,0)
 ;;=4^099.3
 ;;^UTILITY(U,$J,358.3,8590,2)
 ;;=^104534
 ;;^UTILITY(U,$J,358.3,8591,0)
 ;;=112.89^^58^612^5
 ;;^UTILITY(U,$J,358.3,8591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8591,1,3,0)
 ;;=3^Candida,Oth
 ;;^UTILITY(U,$J,358.3,8591,1,4,0)
 ;;=4^112.89
 ;;^UTILITY(U,$J,358.3,8591,2)
 ;;=^87368
 ;;^UTILITY(U,$J,358.3,8592,0)
 ;;=136.1^^58^612^1
 ;;^UTILITY(U,$J,358.3,8592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8592,1,3,0)
 ;;=3^Behcet's Disease
 ;;^UTILITY(U,$J,358.3,8592,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,8592,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,8593,0)
 ;;=190.3^^58^612^11
 ;;^UTILITY(U,$J,358.3,8593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8593,1,3,0)
 ;;=3^Conjunctiva Malig Neopl
 ;;^UTILITY(U,$J,358.3,8593,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,8593,2)
 ;;=^267274
 ;;^UTILITY(U,$J,358.3,8594,0)
 ;;=198.89^^58^612^91
 ;;^UTILITY(U,$J,358.3,8594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8594,1,3,0)
 ;;=3^Uveal Metastasis
 ;;^UTILITY(U,$J,358.3,8594,1,4,0)
 ;;=4^198.89
 ;;^UTILITY(U,$J,358.3,8594,2)
 ;;=^267330
 ;;^UTILITY(U,$J,358.3,8595,0)
 ;;=202.80^^58^612^64
 ;;^UTILITY(U,$J,358.3,8595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8595,1,3,0)
 ;;=3^Lymphoma,Extranod/Solid Org,Unspec Site
 ;;^UTILITY(U,$J,358.3,8595,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,8595,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,8596,0)
 ;;=224.3^^58^612^12
 ;;^UTILITY(U,$J,358.3,8596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8596,1,3,0)
 ;;=3^Conjunctiva,Benign Neopl
 ;;^UTILITY(U,$J,358.3,8596,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,8596,2)
 ;;=^267673
 ;;^UTILITY(U,$J,358.3,8597,0)
 ;;=238.8^^58^612^68
 ;;^UTILITY(U,$J,358.3,8597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8597,1,3,0)
 ;;=3^Neopl,Uncert Behavior,Oth Spec Sites
 ;;^UTILITY(U,$J,358.3,8597,1,4,0)
 ;;=4^238.8
 ;;^UTILITY(U,$J,358.3,8597,2)
 ;;=^267779
 ;;^UTILITY(U,$J,358.3,8598,0)
 ;;=360.11^^58^612^92
 ;;^UTILITY(U,$J,358.3,8598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8598,1,3,0)
 ;;=3^Uveitis Sympathetic
 ;;^UTILITY(U,$J,358.3,8598,1,4,0)
 ;;=4^360.11
 ;;^UTILITY(U,$J,358.3,8598,2)
 ;;=^85809
 ;;^UTILITY(U,$J,358.3,8599,0)
 ;;=360.12^^58^612^74
 ;;^UTILITY(U,$J,358.3,8599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8599,1,3,0)
 ;;=3^Panuveitis
 ;;^UTILITY(U,$J,358.3,8599,1,4,0)
 ;;=4^360.12
 ;;^UTILITY(U,$J,358.3,8599,2)
 ;;=^89553
 ;;^UTILITY(U,$J,358.3,8600,0)
 ;;=360.13^^58^612^51
 ;;^UTILITY(U,$J,358.3,8600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8600,1,3,0)
 ;;=3^Endophthalmitis,Parasitic
 ;;^UTILITY(U,$J,358.3,8600,1,4,0)
 ;;=4^360.13
 ;;^UTILITY(U,$J,358.3,8600,2)
 ;;=^40618
 ;;^UTILITY(U,$J,358.3,8601,0)
 ;;=360.30^^58^612^54
 ;;^UTILITY(U,$J,358.3,8601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8601,1,3,0)
 ;;=3^Hypotony,Unspec
 ;;^UTILITY(U,$J,358.3,8601,1,4,0)
 ;;=4^360.30
 ;;^UTILITY(U,$J,358.3,8601,2)
 ;;=^268556
 ;;^UTILITY(U,$J,358.3,8602,0)
 ;;=363.00^^58^612^8
 ;;^UTILITY(U,$J,358.3,8602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8602,1,3,0)
 ;;=3^Chorioretinitis,Focal,Unspec
 ;;^UTILITY(U,$J,358.3,8602,1,4,0)
 ;;=4^363.00
 ;;^UTILITY(U,$J,358.3,8602,2)
 ;;=^268662
 ;;^UTILITY(U,$J,358.3,8603,0)
 ;;=363.10^^58^612^7
